Palmetto Internal Medicine is categorized under Health Services in Mauldin, SC and active since 2011.
Palmetto Internal Medicine was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Bala Krishniah at the company’s single location by writing to 300 West Butler Road, Mauldin, South Carolina SC 29662 or by phoning (864) 277-8300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Palmetto Internal Medicine |
| Contact Person: | Bala Krishniah |
| Address: | 300 West Butler Road, Mauldin, South Carolina 29662 |
| Phone Number: | (864) 277-8300 |
| Website Address: | my-pim.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Palmetto Internal Medicine was started in 2011 to provide professional Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Bala Krishniah for inquiries that concern Palmetto Internal Medicine by calling the company number (864) 277-8300, as your correspondence is most welcome. Additionally, the physical location of the single location of Palmetto Internal Medicine can be found at the coordinates 34.77642,-82.31529 as well as the street address 300 West Butler Road in Mauldin, South Carolina 29662.
For its online presence, you may visit Palmetto Internal Medicine’s website at my-pim.com and engage with its social media outlets through on Twitter and on Facebook.